Brief: Shenzhen Hepalink Pharma Sees 6-Month Net Profit Up 40.0-60.3% Y/Y
July 13 (Reuters) - Shenzhen Hepalink Pharmaceutical Group
Co Ltd 002399.SZ :
* SAYS IT SEES 6-MONTH NET PROFIT UP 40.0-60.3% Y/Y FROM
338.2
MILLION YUAN ($50.31 million) YEAR EARLIER
Source text http://www.cninfo.com.cn/new/disclosure/detail?stockCode=002399&announcementId=1214025275&orgId=9900012288&announcementTime=2022-07-13
Further company coverage: 002399.SZ
($1 = 6.7217 Chinese yuan renminbi)
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))
Recent news on Shenzhen Hepalink Pharmaceutical Co
See all newsBrief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina
Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA